The EUPHRATES trial : study protocol for a randomized controlled trial

Background Septic shock is common and has unacceptably high morbidity, mortality, and associated cost with numerous failed attempts at developing effective therapies. Endotoxin, one of the most potent mediators of sepsis, is found in high levels in approximately 50% of patients with septic shock. Po...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Trials 2014, Vol.15
Hauptverfasser:	Klein, David J, Foster, Debra, Schorr, Christa A, Kazempour, Kazem, Walker, Paul M, Dellinger, R Phillip
Format:	Report
Sprache:	eng
Schlagworte:	Analysis Care and treatment Development and progression Diagnosis Drug therapy Health aspects Patient outcomes Risk factors Septic shock
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!